Table 4.

Hits from Lambert that could be related to progression in AD for CDR-SB

					Lambert et al		Progression CDR_SB Analysis
SNP	CHR	Gene	Major/Minor	MAF	OR/Beta	P.Value	Beta	P.Value
rs10498633	14	SLC24A4-RIN3	G/T	0.203	0.91/−0.09	5.50×10−09	−0.01	0.07
rs11218343	11	SORL1	T/C	0.040	0.77/−0.26	9.70×10−15	−0.19	0.06
rs6733839	2	BIN1	C/T	0.409	1.22/0.19	6.90×10−44	0.28	0.48
rs10792832	11	PICALM	G/A	0.335	0.87/−0.14	9.30×10−26	−0.001	0.97
rs7274581	20	CASS4	T/C	0.099	0.88/−0.12	2.50×10−08	0.09	0.21
rs28834970	8	PTK2B	T/C	0.364	1.1/0.09	7.40×10−14	0.08	0.06
rs10838725	11	CELF1	T/C	0.296	1.08/0.08	1.10×10−08	−0.04	0.39
rs10948363	6	CD2AP	A/G	0.279	1.1/0.09	5.20×10−11	0.04	0.34
rs35349669	2	INPP5D	C/T	0.476	1.08/0.08	3.20×10−08	0.06	0.12
rs11771145	7	EPHA1	G/A	0.353	0.9/−0.11	1.10×10−13	−0.04	0.35
rs983392	11	MS4A6A	A/G	0.358	0.9/−0.11	6.10×10−16	−0.06	0.12
rs3865444	19	CD33	C/A	0.279	0.94/−0.06	3.00×10−06	−0.04	0.37
rs17125944	14	FERMT2	T/C	0.104	1.14/0.13	7.90×10−09	−0.001	0.89
rs1476679	7	ZCWPW1	T/C	0.263	0.91/−0.09	5.60×10−10	0.004	0.92
rs2718058	7	NME8	A/G	0.361	0.93/−0.07	4.80×10−09	−0.04	0.38
rs8093731	18	DSG2	C/T	0.029	0.73/−0.31	1.00×10−04	−0.05	0.71
rs4147929	19	ABCA7	G/A	0.177	1.15/0.14	1.10×10−15	0.03	0.61
rs6656401	1	CR1	G/A	0.197	1.18/0.17	5.70×10−24	−0.006	0.93
rs9331896	8	CLU	T/C	0.379	0.86/−0.15	2.80×10−25	−0.43	0.28
rs9271192	6	HLA-DRB5-HLA-DRB1	A/C	0.276	1.11/0.14	2.90×10−12	NA	NA
rs190982	5	MEF2C	A/G	0.408	0.93/−0.07	3.20×10−08	0.04	0.59
rs769449	19	APOE	G/A	-	-	-	0.06	0.21

SNP, based on Build 37 of reference genome. MAF, Minor allele frequency. NA no data available.